Pioneering pulmonary drug delivery

Our story

Gilbert’s genesis

Gilbert B.V. (Gilbert) started as a spin-off of Delft University of Technology (TU Delft) where it pioneered the technology for an electrospray nebulizer.

Since 2020 Gilbert is based at the High Tech Campus in Eindhoven.

It’s Gilbert’s mission to make medical treatments easier and more effective for lung patients to extend and improve lives, as well as reduce the burden on the healthcare systems.

Proof-of-Concept

Years of research work at TU Delft, and later by Gilbert, have been dedicated to the demonstration of proof-of-concept of the electrospray technology for respiratory drug delivery and related formulation development for a variety of pharmaceutical compounds. This was successfully done initially on a large benchtop system.

gilbert-technologies-the-basic-principle-e1608285636136 1

From lab to prototype

In 2020 Gilbert advanced from the benchtop system to a functional, handheld prototype device. At the same time Gilbert’s team has been preparing the foundation for meeting the stringent requirements for medical devices. This will allow us to seamlessly develop a safe and effective, CE certifiable investigational device for clinical trial developments.

Recent developments

Today Gilbert is working hard to further develop their Smart Precision Inhaler, a device that can produce a customizable monodisperse aerosol. As of mid 2024, Gilbert is performing feasibility studies with Pharma partners to support the development and formulation for inhaled medicine.

Leveraging the ecosystem

Gilbert draws strength by leveraging the strong ecosystem in the region. Our electrospray technology is based on years of research started at Delft University of Technology and continued at Gilbert.

To advance the electrospray nebulizer technology from the lab to the patient, Gilbert has built an R&D team of seasoned professionals, and along with TU Delft has additionally partnered with Philips Engineering Solutions (PES), its neighbor on the High Tech Campus in Eindhoven and NHL Stenden University of Applied Sciences.

Philips_Shape_Engineering_Solutions_RGB_2021 1

Philips Engineering Solutions

Gilbert is developing the next generation of soft mist inhalers based on proprietary electrospray in partnership with strong collaborators such as Philips.

An experienced and dedicated team

240514_StudioWartenbergh_LookingGlass_Gilbert_05(V3)

Want to be part of Gilbert’s team?

Have a look at our open positions

Open application

Eindhoven, NL

Apply

Board of directors

320626_StudioWartenbergh_LookingGlass_Gilbert_11

George Hersbach

Non-Executive Director, Chairman of the Board

240514_StudioWartenbergh_LookingGlass_Gilbert_03

Ronald Maurer

Non-Executive Director on behalf of DeepTechXL

240514_StudioWartenbergh_LookingGlass_Gilbert_02

Pim Polak

Non-Executive Director on behalf of NanoCorp

320626_StudioWartenbergh_LookingGlass_Gilbert_07

Maurits Huigen

Executive Director, CEO

Scientific advisory board

Prof. Dr. Richard Dekhuijzen

EM. Professor of Pulmonology, University Lung Center Nijmegen, Expert Board ADMIT

Dr.ir.Gabrie Meesters

Associate Professor, Delft University of Technology

Our mission & vision

It’s our mission to make medical treatment easier and more effective for millions of lung patients to extend and improve lives, while reducing the burden of care on the healthcare systems.

We believe in delivering a social contribution to the well-being of people in general and stimulating healthcare improvements in particular, using the ever evolving technological application-possibilities created by science.

The company-based gathering of scientific findings, in a socially and economically responsible way, will be used for product development for further innovation and optimization of healthcare. With the revenues of this, we will facilitate new scientific research.

Drivers, that are crucial for the development of our devices, are:

Efficiency

in administration of medicines

Patient satisfaction

in terms of comfort, mobility and adherence

E-Health

applying smart technologies to improve outcomes

Sustainability

ensuring circular products

EHDA technology has the potential to offer unique benefits to patients for aerosolization and medication targeting of advanced molecular entities for respiratory diseases and for pulmonary administration of molecules for other indication areas.

Our core values

Empathetic

Patients are at the heart of everything we do.

innovative

We develop through smart application of new and disruptive technologies

reliable

We are the trusted company people will turn to for solutions that create a positive impact for patients and society

Circular

We are committed to making the world healthier and more sustainable through innovation, while acting responsibly towards the planet and society.

Investors

In Q2 2023 Gilbert completed its €7 million Seed – and Series A investment round. The investment rounds were led by Dutch deeptech investor DeepTechXL and joined by existing shareholders NanoCorp and Delft Enterprises. With the transaction also Brabant Startup Fonds has become a shareholder, through conversion of its start-up loan to the company.

The equity financing of €4 million is supplemented by the Netherlands Enterprise Agency (RVO.nl) with an innovation credit of €3 million.